chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Brain fog, Cardiac stress test normal, Computerised tomogram heart, Computerised tomogram heart normal
Clinical narrative: Sometime after 9/7/2022, I began to have extreme fatigue and headache. I wasn't able to get out of bed in the morning until late. I became exercise intolerant, and I'm someone who previously exercised every day. I was so fatigued that I had trouble standing up and preparing meals. I also lost my appetite. I found showering to be difficult on account of the extreme fatigue, and I often felt like I would pass out whenever I would try to go about my regular activities. I am now unable to even do basic housework, so I've had to hire someone to come clean my home regularly. Prior to the sudden fatigue, I exercised every day and ate healthy meals. I have also experienced brain fog. I've also had more headaches. I used to talk on the phone quite often, but I now find it too emotionally draining.  I used to keep in touch with my friends, but since I've developed these symptoms, it's been hard for me to communicate with them. On 9/20/2022, I went to my PCP and explained my symptoms to him. He performed bloodwork, and the results were normal. About ten days to two weeks later, I returned with the same symptoms, and I was given a B12 shot. Unfortunately, it didn't do any good. In October 2022, I received a flu shot and a Pfizer bivalent booster. Afterwards, the fatigue intensified. I then went back to my PCP. I then went to a neurologist, who ran an MRI of the brain and brain stem, and the results were normal. In January or February 2023, the neurologist ran an EEG and an EMG, both of which yielded normal results. I went to a different neurologist in April 2023 to get a second opinion. She said that the symptoms could be due to the vaccines, but she wasn't sure. She wanted to give me a stimulant to treat the fatigue, but my insurance company wouldn't cover it, so I ended up not getting it. I went back to the first neurologist in May 2023; he wanted to give me Adderall to see if it would help my fatigue.  He gave me the Adderall, but I haven't yet taken it, because I have concerns about it. In May 2023, I went to a cardiologist, who performed a stress test and an electrocardiogram. The results were normal. In June 2023, I underwent a CT scan of my heart and arteries. I just saw the cardiologist again on 7/20/2023, and he said that my arteries were like those of an 18-year-old. The cardiologist told me that it was possible that my fatigue was due to the COVID-19 vaccines and boosters I have received, and he advised me to follow up with the CDC. He also said that he has seen other patients develop various symptoms after the vaccines that they did not have prior to the vaccines.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysstasia, Electrocardiogram normal, Electroencephalogram normal, Electromyogram normal
Clinical narrative: Sometime after 9/7/2022, I began to have extreme fatigue and headache. I wasn't able to get out of bed in the morning until late. I became exercise intolerant, and I'm someone who previously exercised every day. I was so fatigued that I had trouble standing up and preparing meals. I also lost my appetite. I found showering to be difficult on account of the extreme fatigue, and I often felt like I would pass out whenever I would try to go about my regular activities. I am now unable to even do basic housework, so I've had to hire someone to come clean my home regularly. Prior to the sudden fatigue, I exercised every day and ate healthy meals. I have also experienced brain fog. I've also had more headaches. I used to talk on the phone quite often, but I now find it too emotionally draining.  I used to keep in touch with my friends, but since I've developed these symptoms, it's been hard for me to communicate with them. On 9/20/2022, I went to my PCP and explained my symptoms to him. He performed bloodwork, and the results were normal. About ten days to two weeks later, I returned with the same symptoms, and I was given a B12 shot. Unfortunately, it didn't do any good. In October 2022, I received a flu shot and a Pfizer bivalent booster. Afterwards, the fatigue intensified. I then went back to my PCP. I then went to a neurologist, who ran an MRI of the brain and brain stem, and the results were normal. In January or February 2023, the neurologist ran an EEG and an EMG, both of which yielded normal results. I went to a different neurologist in April 2023 to get a second opinion. She said that the symptoms could be due to the vaccines, but she wasn't sure. She wanted to give me a stimulant to treat the fatigue, but my insurance company wouldn't cover it, so I ended up not getting it. I went back to the first neurologist in May 2023; he wanted to give me Adderall to see if it would help my fatigue.  He gave me the Adderall, but I haven't yet taken it, because I have concerns about it. In May 2023, I went to a cardiologist, who performed a stress test and an electrocardiogram. The results were normal. In June 2023, I underwent a CT scan of my heart and arteries. I just saw the cardiologist again on 7/20/2023, and he said that my arteries were like those of an 18-year-old. The cardiologist told me that it was possible that my fatigue was due to the COVID-19 vaccines and boosters I have received, and he advised me to follow up with the CDC. He also said that he has seen other patients develop various symptoms after the vaccines that they did not have prior to the vaccines.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Exercise tolerance decreased, Fatigue, Headache, Loss of personal independence in daily activities, Magnetic resonance imaging head normal
Clinical narrative: Sometime after 9/7/2022, I began to have extreme fatigue and headache. I wasn't able to get out of bed in the morning until late. I became exercise intolerant, and I'm someone who previously exercised every day. I was so fatigued that I had trouble standing up and preparing meals. I also lost my appetite. I found showering to be difficult on account of the extreme fatigue, and I often felt like I would pass out whenever I would try to go about my regular activities. I am now unable to even do basic housework, so I've had to hire someone to come clean my home regularly. Prior to the sudden fatigue, I exercised every day and ate healthy meals. I have also experienced brain fog. I've also had more headaches. I used to talk on the phone quite often, but I now find it too emotionally draining.  I used to keep in touch with my friends, but since I've developed these symptoms, it's been hard for me to communicate with them. On 9/20/2022, I went to my PCP and explained my symptoms to him. He performed bloodwork, and the results were normal. About ten days to two weeks later, I returned with the same symptoms, and I was given a B12 shot. Unfortunately, it didn't do any good. In October 2022, I received a flu shot and a Pfizer bivalent booster. Afterwards, the fatigue intensified. I then went back to my PCP. I then went to a neurologist, who ran an MRI of the brain and brain stem, and the results were normal. In January or February 2023, the neurologist ran an EEG and an EMG, both of which yielded normal results. I went to a different neurologist in April 2023 to get a second opinion. She said that the symptoms could be due to the vaccines, but she wasn't sure. She wanted to give me a stimulant to treat the fatigue, but my insurance company wouldn't cover it, so I ended up not getting it. I went back to the first neurologist in May 2023; he wanted to give me Adderall to see if it would help my fatigue.  He gave me the Adderall, but I haven't yet taken it, because I have concerns about it. In May 2023, I went to a cardiologist, who performed a stress test and an electrocardiogram. The results were normal. In June 2023, I underwent a CT scan of my heart and arteries. I just saw the cardiologist again on 7/20/2023, and he said that my arteries were like those of an 18-year-old. The cardiologist told me that it was possible that my fatigue was due to the COVID-19 vaccines and boosters I have received, and he advised me to follow up with the CDC. He also said that he has seen other patients develop various symptoms after the vaccines that they did not have prior to the vaccines.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased
Clinical narrative: Sometime after 9/7/2022, I began to have extreme fatigue and headache. I wasn't able to get out of bed in the morning until late. I became exercise intolerant, and I'm someone who previously exercised every day. I was so fatigued that I had trouble standing up and preparing meals. I also lost my appetite. I found showering to be difficult on account of the extreme fatigue, and I often felt like I would pass out whenever I would try to go about my regular activities. I am now unable to even do basic housework, so I've had to hire someone to come clean my home regularly. Prior to the sudden fatigue, I exercised every day and ate healthy meals. I have also experienced brain fog. I've also had more headaches. I used to talk on the phone quite often, but I now find it too emotionally draining.  I used to keep in touch with my friends, but since I've developed these symptoms, it's been hard for me to communicate with them. On 9/20/2022, I went to my PCP and explained my symptoms to him. He performed bloodwork, and the results were normal. About ten days to two weeks later, I returned with the same symptoms, and I was given a B12 shot. Unfortunately, it didn't do any good. In October 2022, I received a flu shot and a Pfizer bivalent booster. Afterwards, the fatigue intensified. I then went back to my PCP. I then went to a neurologist, who ran an MRI of the brain and brain stem, and the results were normal. In January or February 2023, the neurologist ran an EEG and an EMG, both of which yielded normal results. I went to a different neurologist in April 2023 to get a second opinion. She said that the symptoms could be due to the vaccines, but she wasn't sure. She wanted to give me a stimulant to treat the fatigue, but my insurance company wouldn't cover it, so I ended up not getting it. I went back to the first neurologist in May 2023; he wanted to give me Adderall to see if it would help my fatigue.  He gave me the Adderall, but I haven't yet taken it, because I have concerns about it. In May 2023, I went to a cardiologist, who performed a stress test and an electrocardiogram. The results were normal. In June 2023, I underwent a CT scan of my heart and arteries. I just saw the cardiologist again on 7/20/2023, and he said that my arteries were like those of an 18-year-old. The cardiologist told me that it was possible that my fatigue was due to the COVID-19 vaccines and boosters I have received, and he advised me to follow up with the CDC. He also said that he has seen other patients develop various symptoms after the vaccines that they did not have prior to the vaccines.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Neuropathy peripheral, Symptom recurrence
Clinical narrative: PERIPHERAL NEUROPATHY 2/24/2023  &  3/1/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension, Neuropathy peripheral
Clinical narrative: NEUROPATHY HYPOTENSION
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse effects reported
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 1.0
Sex: F
Vaccine: MMRV
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Writer went and got immunizations for patient ready and brough to two different coworkers to make sure everything looked good. Was told the immunizations were correct and writer and two coworkers walked into the room and gave the patient her immunizations. As writer was trying to document the vaccinations, writer noticed that instead of just the MMR vaccine the patient was given the MMR+V (proquad). Patient's mother was notified and told to watch for fevers and rashes and that the patient did end up getting a double dose of the varicella vaccine in the MMR+V and the plain varicella vaccine. Writer checked on the patient and there had been no changes.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cardiogenic shock, Symptom recurrence
Clinical narrative: CARDIOGENIC SHOCK 2/28/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Vaccines given on 7/18/23 in L arm. Mom states today she noticed that L arm is red and swollen; about 70% of her upper arm. Area warm to touch. Not tender to touch or painful. Acting well otherwise.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine dose administered five days past its beyond use date (BUD was 01/11/2023). No adverse reaction observed or reported to Health Department.
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: No adverse effects reported
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lacunar stroke
Clinical narrative: ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Ischaemic stroke, Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 71.0
Sex: F
Vaccine: MNQ
Symptoms: Wrong product administered
Clinical narrative: Patient was to receive Shingrix vaccination. Vials pulled from box were for Menveo vaccination. Vials were not verified, only information on box. When document, error was noticed. Provider and patient were both notified. Patient is not having any adverse reactions.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Product storage error
Clinical narrative: The vaccines in our office had a temperature excursion - the vaccines were too cold - following speaking with MERCK, we were told the vaccines were no longer stable to use   Patient was accidentally given a dose of these vaccines that are waiting to be sent back to the program  Patient mother aware; MERCK stated the patient will need to repeat the dose - spoke with doctor and the attending doctor in the office at the time
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reaction reported
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reaction reported
Age: 37.0
Sex: F
Vaccine: COVID19-2
Symptoms: Intermenstrual bleeding, Migraine, Migraine with aura
Clinical narrative: Migraine headache with aura began six hours after injection and lasted one hour. Menstrual spotting lasting one day has occurred twice since the injection
Age: 13.0
Sex: M
Vaccine: DTAP
Symptoms: Wrong product administered
Clinical narrative: This clinic was to administer Tdap as a follow up booster from the original DTaP but administered a DTaP to my child in error.  They realized the error in noticing the lot number did not align with the correct vaccine and a supervisor followed up with me explaining that DTaP can be given in place of Tdap if Tdap is not available. The instance of administering the DTaP was an error due to negligence at the clinic. Though there is unlikely to be a safety risk to my child due to this error, a clinic administering the wrong vaccine on accident should be reported.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Angina unstable
Clinical narrative: UNSTABLE ANGINA ACUTE NON ST ELEVATION MI
Age: 13.0
Sex: F
Vaccine: DTAP
Symptoms: Wrong product administered, Wrong technique in product usage process
Clinical narrative: This clinic was to administer Tdap as a follow up booster from the original DTaP but administered a DTaP to my child in error.  They realized the error in noticing the lot number did not align with the correct vaccine and a supervisor followed up with me explaining that DTaP can be given in place of Tdap if Tdap is not available. The instance of administering the DTaP was an error due to negligence at the clinic. Though there is unlikely to be a safety risk to my child due to this error, a clinic administering the wrong vaccine on accident should be reported. Additionally, the nurse withdrew the needle prematurely before administering the full dose and upon realization injected the needle back into my child to finish administering the remaining vaccine dose.
Age: 0.75
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Moderna bivalent Pink cap was administered when Moderna bivalent Blue cap should have been administered.
Age: 88.0
Sex: M
Vaccine: COVID19-2
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Antiphospholipid antibodies, Blood test abnormal, Burning sensation, C-reactive protein increased, Cardiac monitoring
Clinical narrative: First day I was fine I was the normal symptoms. The next day my legs paralyze from my hips to all the way down to my feet. I couldn't move them. They were burning and tingly like on fire. It's been 2 years and I am still going through the same thing. My hear sometimes it starts racing really fast making it hard for me to breathe.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Dyspnoea, Electrocardiogram, Inflammation, Magnetic resonance imaging spinal abnormal
Clinical narrative: First day I was fine I was the normal symptoms. The next day my legs paralyze from my hips to all the way down to my feet. I couldn't move them. They were burning and tingly like on fire. It's been 2 years and I am still going through the same thing. My hear sometimes it starts racing really fast making it hard for me to breathe.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Monoplegia, Palpitations, Paraesthesia
Clinical narrative: First day I was fine I was the normal symptoms. The next day my legs paralyze from my hips to all the way down to my feet. I couldn't move them. They were burning and tingly like on fire. It's been 2 years and I am still going through the same thing. My hear sometimes it starts racing really fast making it hard for me to breathe.
Age: 0.75
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Moderna bivalent Pink cap was administered when Moderna bivalent Blue cap should have been administered.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Nausea, Pain, Vomiting
Clinical narrative: Extreme aches all over body, chills, nauseous, vomiting
Age: 67.0
Sex: M
Vaccine: PNC20
Symptoms: No adverse event, Product administration error, Wrong product administered
Clinical narrative: Patient's physician ordered Pneumococcal 23 but was given Prevnar 20 instead. The error was realized and the patient was called back to the clinic where side effects of all the pneumococcal vaccines were discussed, as well as recommendations to get either Pneumococcal 23 or conjugated pneumococcal 13 in 2 years. The patient did not have adverse effects from the incorrect vaccine administration.
Age: 18.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Site redness and pain; started on Keflex 500 mg TID for 7 days on 7/21/23
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, Death, Depressed level of consciousness, Dyspnoea
Clinical narrative: Patient is a 85 y.o. male with a past medical history that includes chronic restrictive lung disease in the setting of kyphosis, CVA with chronic dysphagia s/p G-tube, prior aspiration PNA requiring intubation, incarcerated paraesophageal hernia, osteoporosis, hyperlipidemia, GERD, BPH, osteoarthritis, vertebral compression fractures.  He presented on 5/7/2023 with 4 days of shortness of breath, found to be in acute hypoxic respiratory failure secondary to COVID/aspiration pneumonia. On BiPAP, steroids, remdesivir, rocephin. Overnight 5/10, patient became more somnolent and difficult to arouse with labored breathing. Discussed change with wife, POA, and decision was made to transition care to comfort measures only. Time of death 1017
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pneumonia aspiration, Positive airway pressure therapy, Somnolence
Clinical narrative: Patient is a 85 y.o. male with a past medical history that includes chronic restrictive lung disease in the setting of kyphosis, CVA with chronic dysphagia s/p G-tube, prior aspiration PNA requiring intubation, incarcerated paraesophageal hernia, osteoporosis, hyperlipidemia, GERD, BPH, osteoarthritis, vertebral compression fractures.  He presented on 5/7/2023 with 4 days of shortness of breath, found to be in acute hypoxic respiratory failure secondary to COVID/aspiration pneumonia. On BiPAP, steroids, remdesivir, rocephin. Overnight 5/10, patient became more somnolent and difficult to arouse with labored breathing. Discussed change with wife, POA, and decision was made to transition care to comfort measures only. Time of death 1017
Age: 12.0
Sex: M
Vaccine: MMRV
Symptoms: Fall, Loss of consciousness, Seizure
Clinical narrative: Gave pt. MMRV and Meningo vaccine in Left arm had pt. stand up I moved the chair around to give Hep A in Right arm.The pt. started to pass out and fall towards me I caught him and sat him up and he started to seize. Others came over and we started vitals and someone called emergency services at 1403. B/P 90/60 Pulse 91 and O2 100% at 1406. At 1408 Pulse was 61. Fire dept. showed up at 1409   Pt. seemed alert and able to answer questions. At 1414 anbulance showed up and took over patient walked to stretcher and was taken to Hospital.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Dyspnoea, Erythema, Fatigue, Nausea, Swelling face
Clinical narrative: Patient experienced fatigue , nausea, and shortness of breath the same day several hours after the vaccination. Symptoms improved within 48 hours but experienced redness and swelling in the face 3 days after vaccination.  Patient did not seek urgent medical attention and planned to self treat with antihistamines.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: numbness in fingers
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Drug hypersensitivity, Pain, Pain in extremity
Clinical narrative: Patient states Moderna booster shot on 7/25/22 caused reaction within hours of pain starting in right arm and shoulder which then radiated to left shoulder and arm and down both arms to hands right greater than left.  She felt like her "bones were one fire" and couldn't touch her skin was very sensitive, noted swelling.  Also reported fever.  States the pain lasted for months and then resolved however it occasionally returns as similar pain at random times and then will go away. Can no longer tolerate allergy shots.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Sensitive skin, Swelling
Clinical narrative: Patient states Moderna booster shot on 7/25/22 caused reaction within hours of pain starting in right arm and shoulder which then radiated to left shoulder and arm and down both arms to hands right greater than left.  She felt like her "bones were one fire" and couldn't touch her skin was very sensitive, noted swelling.  Also reported fever.  States the pain lasted for months and then resolved however it occasionally returns as similar pain at random times and then will go away. Can no longer tolerate allergy shots.
Age: 93.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Affective disorder, Atelectasis, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Patient is a 94 y.o. male with a history of CKD and BPH who presented to a HCF 5/8/2023 from a senior living facility for 1-2 days of malaise and diarrhea. CXR showed left hilar markings concerning for early infiltrate. Found to have COVID-19 pneumonia and rotavirus. Discharged back to Assisted Living facility 5/10/23.   1. Acute hypoxemic respiratory failure: Suspect related to COVID-19 pneumonia. No evidence of bacterial PNA. CXR showed left hilar markings, infiltrate vs atelectasis. Improved. 2. COVID-19 Pneumonia: initially negative on admit. Positive 5/9/23. Improved to room air 5/9/23. ID econsulted for paxlovid.  3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. 3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. Suspect related to acute infections. Therapies followed. Improved. 4. Acute Diarrhea: Developed over past 48 hrs PTA. Reported outbreak of gastroenteritis at his facility. No recent ATB. GI consulted for melena noted 5/9/23. Stool PCR with rotavirus. Imodium prn. 5. Melena: GI deferred EGD. Hb remained stable. GI recommended PPI BID x 1 month. Consider OP endoscopies. 6. Dysphagia: SLP recommended chopped solids with thin liquids per MBS 5/10/23. 7. Abnormal Urinalysis: UA with 22 WBCs. Started on IV rocephin on admit. Culture collected 5/9/23. Completed 3 day course of rocephin 5/10/23. 8. Elevated troponin: Troponin 86 on admission. Delta of -5. ECG showed chronic non-specific t wave changes. Demand ischemia. No further inpatient workup. 9. Mood disorder: held buspar while on paxlovid and additional 3 days afterwards.
Age: 93.0
Sex: M
Vaccine: COVID19-2
Symptoms: Culture urine, Diarrhoea, Dysphagia, Electrocardiogram T wave abnormal, Haemoglobin normal
Clinical narrative: Patient is a 94 y.o. male with a history of CKD and BPH who presented to a HCF 5/8/2023 from a senior living facility for 1-2 days of malaise and diarrhea. CXR showed left hilar markings concerning for early infiltrate. Found to have COVID-19 pneumonia and rotavirus. Discharged back to Assisted Living facility 5/10/23.   1. Acute hypoxemic respiratory failure: Suspect related to COVID-19 pneumonia. No evidence of bacterial PNA. CXR showed left hilar markings, infiltrate vs atelectasis. Improved. 2. COVID-19 Pneumonia: initially negative on admit. Positive 5/9/23. Improved to room air 5/9/23. ID econsulted for paxlovid.  3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. 3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. Suspect related to acute infections. Therapies followed. Improved. 4. Acute Diarrhea: Developed over past 48 hrs PTA. Reported outbreak of gastroenteritis at his facility. No recent ATB. GI consulted for melena noted 5/9/23. Stool PCR with rotavirus. Imodium prn. 5. Melena: GI deferred EGD. Hb remained stable. GI recommended PPI BID x 1 month. Consider OP endoscopies. 6. Dysphagia: SLP recommended chopped solids with thin liquids per MBS 5/10/23. 7. Abnormal Urinalysis: UA with 22 WBCs. Started on IV rocephin on admit. Culture collected 5/9/23. Completed 3 day course of rocephin 5/10/23. 8. Elevated troponin: Troponin 86 on admission. Delta of -5. ECG showed chronic non-specific t wave changes. Demand ischemia. No further inpatient workup. 9. Mood disorder: held buspar while on paxlovid and additional 3 days afterwards.
Age: 93.0
Sex: M
Vaccine: COVID19-2
Symptoms: Laboratory test abnormal, Lung infiltration, Malaise, Melaena, Metabolic encephalopathy
Clinical narrative: Patient is a 94 y.o. male with a history of CKD and BPH who presented to a HCF 5/8/2023 from a senior living facility for 1-2 days of malaise and diarrhea. CXR showed left hilar markings concerning for early infiltrate. Found to have COVID-19 pneumonia and rotavirus. Discharged back to Assisted Living facility 5/10/23.   1. Acute hypoxemic respiratory failure: Suspect related to COVID-19 pneumonia. No evidence of bacterial PNA. CXR showed left hilar markings, infiltrate vs atelectasis. Improved. 2. COVID-19 Pneumonia: initially negative on admit. Positive 5/9/23. Improved to room air 5/9/23. ID econsulted for paxlovid.  3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. 3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. Suspect related to acute infections. Therapies followed. Improved. 4. Acute Diarrhea: Developed over past 48 hrs PTA. Reported outbreak of gastroenteritis at his facility. No recent ATB. GI consulted for melena noted 5/9/23. Stool PCR with rotavirus. Imodium prn. 5. Melena: GI deferred EGD. Hb remained stable. GI recommended PPI BID x 1 month. Consider OP endoscopies. 6. Dysphagia: SLP recommended chopped solids with thin liquids per MBS 5/10/23. 7. Abnormal Urinalysis: UA with 22 WBCs. Started on IV rocephin on admit. Culture collected 5/9/23. Completed 3 day course of rocephin 5/10/23. 8. Elevated troponin: Troponin 86 on admission. Delta of -5. ECG showed chronic non-specific t wave changes. Demand ischemia. No further inpatient workup. 9. Mood disorder: held buspar while on paxlovid and additional 3 days afterwards.
Age: 93.0
Sex: M
Vaccine: COVID19-2
Symptoms: Myocardial ischaemia, Rotavirus infection, Rotavirus test positive, SARS-CoV-2 test positive, Stool analysis abnormal
Clinical narrative: Patient is a 94 y.o. male with a history of CKD and BPH who presented to a HCF 5/8/2023 from a senior living facility for 1-2 days of malaise and diarrhea. CXR showed left hilar markings concerning for early infiltrate. Found to have COVID-19 pneumonia and rotavirus. Discharged back to Assisted Living facility 5/10/23.   1. Acute hypoxemic respiratory failure: Suspect related to COVID-19 pneumonia. No evidence of bacterial PNA. CXR showed left hilar markings, infiltrate vs atelectasis. Improved. 2. COVID-19 Pneumonia: initially negative on admit. Positive 5/9/23. Improved to room air 5/9/23. ID econsulted for paxlovid.  3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. 3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. Suspect related to acute infections. Therapies followed. Improved. 4. Acute Diarrhea: Developed over past 48 hrs PTA. Reported outbreak of gastroenteritis at his facility. No recent ATB. GI consulted for melena noted 5/9/23. Stool PCR with rotavirus. Imodium prn. 5. Melena: GI deferred EGD. Hb remained stable. GI recommended PPI BID x 1 month. Consider OP endoscopies. 6. Dysphagia: SLP recommended chopped solids with thin liquids per MBS 5/10/23. 7. Abnormal Urinalysis: UA with 22 WBCs. Started on IV rocephin on admit. Culture collected 5/9/23. Completed 3 day course of rocephin 5/10/23. 8. Elevated troponin: Troponin 86 on admission. Delta of -5. ECG showed chronic non-specific t wave changes. Demand ischemia. No further inpatient workup. 9. Mood disorder: held buspar while on paxlovid and additional 3 days afterwards.
Age: 93.0
Sex: M
Vaccine: COVID19-2
Symptoms: Troponin increased, Urine analysis abnormal, White blood cells urine positive
Clinical narrative: Patient is a 94 y.o. male with a history of CKD and BPH who presented to a HCF 5/8/2023 from a senior living facility for 1-2 days of malaise and diarrhea. CXR showed left hilar markings concerning for early infiltrate. Found to have COVID-19 pneumonia and rotavirus. Discharged back to Assisted Living facility 5/10/23.   1. Acute hypoxemic respiratory failure: Suspect related to COVID-19 pneumonia. No evidence of bacterial PNA. CXR showed left hilar markings, infiltrate vs atelectasis. Improved. 2. COVID-19 Pneumonia: initially negative on admit. Positive 5/9/23. Improved to room air 5/9/23. ID econsulted for paxlovid.  3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. 3. Acute metabolic encephalopathy: CAM positive on initial evaluation of letter testing. Suspect related to acute infections. Therapies followed. Improved. 4. Acute Diarrhea: Developed over past 48 hrs PTA. Reported outbreak of gastroenteritis at his facility. No recent ATB. GI consulted for melena noted 5/9/23. Stool PCR with rotavirus. Imodium prn. 5. Melena: GI deferred EGD. Hb remained stable. GI recommended PPI BID x 1 month. Consider OP endoscopies. 6. Dysphagia: SLP recommended chopped solids with thin liquids per MBS 5/10/23. 7. Abnormal Urinalysis: UA with 22 WBCs. Started on IV rocephin on admit. Culture collected 5/9/23. Completed 3 day course of rocephin 5/10/23. 8. Elevated troponin: Troponin 86 on admission. Delta of -5. ECG showed chronic non-specific t wave changes. Demand ischemia. No further inpatient workup. 9. Mood disorder: held buspar while on paxlovid and additional 3 days afterwards.
Age: 1.42
Sex: M
Vaccine: DTAPHEPBIP, HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: No adverse event, Vaccination error
Clinical narrative: PT received dose of IPV that he did not need today. No adverse reaction, none treatment needed.
Age: 66.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Asthenia, Pain
Clinical narrative: weakness and pain all over my body
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, Computerised tomogram thorax normal, Cough, Dyspnoea
Clinical narrative: Patient is a 82 y.o. female with multiple medical problems including history of pulmonary hypertension, hypertension, fibromyalgia, left knee osteoarthritis status post recent left TKA with development of postoperative hypoxia requiring home oxygen therapy who presented from home on 5/20/2023 with complaints of increasing shortness of breath and noted dyspnea at home; found to be COVID-19 positive. She was noted to be Hypoxic requiring O2 therapy. Per current COVID guidelines, she was started on Decadron along with IV Remdesivir. CT imaging showed no evidence of consolidative changes.  Throughout hospitalization her breathing improved and she is currently not requiring oxygen therapy during the day. PT/OT did follow along and recommending HHC at DC, however pt declined as she is already set up with OP therapy and she wishes for this to continue  Acute on chronic respiratory failure with hypoxia COVID-19 Infection - Presented with: cough, congestion and mild sputum production - Symptom onset: 5/13/2023 - Positive COVID-19: 5/20/2023 at Facility ED - Vaccination status: Vaccinated x4 with Pfizer - CT Chest on admission showed no evidence of consolidative changes - Oxygen status: initially required 1 to 2 L nasal cannula ATC (baseline wears 1-2L nocturnal); currently on RA during the day  - Decadron: Yes. Expected end date 5/30/2023 - Remdesivir: initiated while inpatient - last dose 5/24 - DVT prophylaxis: ASA - Serial COVID labs ordered: No - Case Management/Social Services consulted: No
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia, Productive cough, Respiratory failure, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Patient is a 82 y.o. female with multiple medical problems including history of pulmonary hypertension, hypertension, fibromyalgia, left knee osteoarthritis status post recent left TKA with development of postoperative hypoxia requiring home oxygen therapy who presented from home on 5/20/2023 with complaints of increasing shortness of breath and noted dyspnea at home; found to be COVID-19 positive. She was noted to be Hypoxic requiring O2 therapy. Per current COVID guidelines, she was started on Decadron along with IV Remdesivir. CT imaging showed no evidence of consolidative changes.  Throughout hospitalization her breathing improved and she is currently not requiring oxygen therapy during the day. PT/OT did follow along and recommending HHC at DC, however pt declined as she is already set up with OP therapy and she wishes for this to continue  Acute on chronic respiratory failure with hypoxia COVID-19 Infection - Presented with: cough, congestion and mild sputum production - Symptom onset: 5/13/2023 - Positive COVID-19: 5/20/2023 at Facility ED - Vaccination status: Vaccinated x4 with Pfizer - CT Chest on admission showed no evidence of consolidative changes - Oxygen status: initially required 1 to 2 L nasal cannula ATC (baseline wears 1-2L nocturnal); currently on RA during the day  - Decadron: Yes. Expected end date 5/30/2023 - Remdesivir: initiated while inpatient - last dose 5/24 - DVT prophylaxis: ASA - Serial COVID labs ordered: No - Case Management/Social Services consulted: No
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, Atrial fibrillation, Blood lactic acid, COVID-19
Clinical narrative: Patient is a 68 y.o. male patient of DO with history of afib, lymphoma presented to Medical Center with generalized weakness, found to have sepsis 2/2 COVID and afib with RVR.   Sepsis - resolved Covid-19 Virus Infection Date of onset of symptoms: 5/13/23 Symptoms present on admission: weakness, dyspnea Date of covid positive test: 05/15/23  Vaccination status: vaccinated Imaging: CXR nonacute Oxygen requirements on admission: none Current oxygen requirements: 2LNC Pulm/CC consulted ID consulted, plan for 3 days of Remdesivir, cannot get paxlovid due to interactions with Xarelto.    Afib with RVR - resolved HR 140s on presentation Transitioned off of Cardizem gtt Resume home Xarelt Resume home Xarelto, Toprol, ASA Cardiology consulted, have signed off Currently on oral metoprolol Rate controlled.   DM2 Holding home metformin, glipizide A1c 6.4 in 3/2023, below goal for age Can likely DC glipizide on discharge and just continue metformin Afib with RVR - resolved HR 140s on presentation Transitioned off of Cardizem gtt Resume home Xarelto, Toprol, ASA Cardiology consulted, have signed off Currently on oral metoprolol Rate controlled.   DM2 Holding home metformin, glipizide A1c 6.4 in 3/2023, below goal for age Can likely DC glipizide on discharge and just continue metformin   Lymphoma Thrombocytopenia Next chemo due 5/16 Continue home Bactrim and acyclovir for infection ppx Consult oncology, follows with Dr - no further workup or therapy until after COVID.    HTN Home lisinopril, metoprolol BP low normal May be able to DC lisinopril on discharge   Lactic acidosis, POA.  3.6 on admission Trended down to 2.0
Sex: M
Vaccine: COVID19
Symptoms: Chemotherapy, Chest X-ray normal, Condition aggravated, Dyspnoea, Glycosylated haemoglobin normal
Clinical narrative: Patient is a 68 y.o. male patient of DO with history of afib, lymphoma presented to Medical Center with generalized weakness, found to have sepsis 2/2 COVID and afib with RVR.   Sepsis - resolved Covid-19 Virus Infection Date of onset of symptoms: 5/13/23 Symptoms present on admission: weakness, dyspnea Date of covid positive test: 05/15/23  Vaccination status: vaccinated Imaging: CXR nonacute Oxygen requirements on admission: none Current oxygen requirements: 2LNC Pulm/CC consulted ID consulted, plan for 3 days of Remdesivir, cannot get paxlovid due to interactions with Xarelto.    Afib with RVR - resolved HR 140s on presentation Transitioned off of Cardizem gtt Resume home Xarelt Resume home Xarelto, Toprol, ASA Cardiology consulted, have signed off Currently on oral metoprolol Rate controlled.   DM2 Holding home metformin, glipizide A1c 6.4 in 3/2023, below goal for age Can likely DC glipizide on discharge and just continue metformin Afib with RVR - resolved HR 140s on presentation Transitioned off of Cardizem gtt Resume home Xarelto, Toprol, ASA Cardiology consulted, have signed off Currently on oral metoprolol Rate controlled.   DM2 Holding home metformin, glipizide A1c 6.4 in 3/2023, below goal for age Can likely DC glipizide on discharge and just continue metformin   Lymphoma Thrombocytopenia Next chemo due 5/16 Continue home Bactrim and acyclovir for infection ppx Consult oncology, follows with Dr - no further workup or therapy until after COVID.    HTN Home lisinopril, metoprolol BP low normal May be able to DC lisinopril on discharge   Lactic acidosis, POA.  3.6 on admission Trended down to 2.0
Sex: M
Vaccine: COVID19
Symptoms: Lactic acidosis, Lymphoma, SARS-CoV-2 test positive, Sepsis, Thrombocytopenia
Clinical narrative: Patient is a 68 y.o. male patient of DO with history of afib, lymphoma presented to Medical Center with generalized weakness, found to have sepsis 2/2 COVID and afib with RVR.   Sepsis - resolved Covid-19 Virus Infection Date of onset of symptoms: 5/13/23 Symptoms present on admission: weakness, dyspnea Date of covid positive test: 05/15/23  Vaccination status: vaccinated Imaging: CXR nonacute Oxygen requirements on admission: none Current oxygen requirements: 2LNC Pulm/CC consulted ID consulted, plan for 3 days of Remdesivir, cannot get paxlovid due to interactions with Xarelto.    Afib with RVR - resolved HR 140s on presentation Transitioned off of Cardizem gtt Resume home Xarelt Resume home Xarelto, Toprol, ASA Cardiology consulted, have signed off Currently on oral metoprolol Rate controlled.   DM2 Holding home metformin, glipizide A1c 6.4 in 3/2023, below goal for age Can likely DC glipizide on discharge and just continue metformin Afib with RVR - resolved HR 140s on presentation Transitioned off of Cardizem gtt Resume home Xarelto, Toprol, ASA Cardiology consulted, have signed off Currently on oral metoprolol Rate controlled.   DM2 Holding home metformin, glipizide A1c 6.4 in 3/2023, below goal for age Can likely DC glipizide on discharge and just continue metformin   Lymphoma Thrombocytopenia Next chemo due 5/16 Continue home Bactrim and acyclovir for infection ppx Consult oncology, follows with Dr - no further workup or therapy until after COVID.    HTN Home lisinopril, metoprolol BP low normal May be able to DC lisinopril on discharge   Lactic acidosis, POA.  3.6 on admission Trended down to 2.0
Age: 12.0
Sex: M
Vaccine: MENB
Symptoms: Unevaluable event
Clinical narrative: provider notified parents
Age: 21.0
Sex: M
Vaccine: TD
Symptoms: Axillary pain, Erythema, Injection site reaction, Pain in extremity, Pruritus
Clinical narrative: Patient came in to show us his arm, which was red and painful. Patient also stated area was itchy and under his armpits were also slightly painful. He informed us he took an Advil to help with the soreness.  I informed the patient that most of the symptoms he is experiencing is consistent with an injection site reaction. He was advised to continue to take advil every 6 hours along with applying an ice pack. He was also advised to go to an urgent care, should his symptoms get worse or if he is not better within 7 days of onset.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: The adverse event that took place was that the second dose in the COVID-19 Pfizer monovalent two-dose series was given to the patient too soon after his first dose. According to CAIR, the patient received a first dose of Pfizer on 3/30/2023. This early administration occurred during a pop-up clinic that our Covid Team held on 4/6/2023 at Harm Reduction Services (2800 Stockton Blvd, Sacramento, CA 95817). I am reporting this event as I discovered this error while performing quality assurance checks on our past clinics, but was not present in the vaccination area while this patient was vaccinated. There were no report of any patients having any adverse effects at this clinic, and no patients showed any signs or symptoms after being vaccinated.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: patient was administered vaccine that was beyond its BUD BUD:07/06/2023
Sex: M
Vaccine: VARZOS
Symptoms: Contraindicated product administered
Clinical narrative: Patient with type 2 diabetes reported as "uncontrolled" was vaccinated with Zostavax; Information has been received from the authors in the published literature article entitled as stated below, referring to an 83-year-old male patient with type 2 diabetes reported as "uncontrolled" (A1C hemoglobin result of 10.9 (units not provided)). According to the authors, this patient's condition was considered as an immunocompromised state.  On an unknown date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) subcutaneous injection, administered for prophylaxis (lot #, expiry date, route of administration, and anatomical location were not provided) (contraindicated product administered).  A copy of the published article is attached as further documentation of the patient's experience.  Literature report.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE information; HCP (nurse) called to report TE for VARIVAX (lot: W031813 expiration: 10/05/2024) that occurred on 05/11/2023 but she was not made aware until today (06/26/2023).  The product was stored at 10.8F for 8 hours, 23 minutes and 0 seconds with; This spontaneous report was received from a Nurse and refers to a 5-year-old patient of unknown gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not provided.  On 05-JUN-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter, lot #W031813, expiration date: 05-OCT-2024, administered for prophylaxis (anatomical location, strength, and route of administration were not provided). The product was stored at 10.8F for 8 hours, 23 minutes and 0 seconds with a supported temperature excursion (TE) stability evaluation. There were no any previous excursions. No adverse outcomes or side effects were reported.  This is one of the nine reports from the same reporter.; Sender's Comments:  US-009507513-2306USA012702: US-009507513-2306USA012560: US-009507513-2306USA012315: US-009507513-2306USA012318: US-009507513-2306USA012351: US-009507513-2306USA012355: US-009507513-2306USA012732: US-009507513-2306USA012753:
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: no adverse event; HBP calling to report a misuse AE with an administration of a second dose of PROQUAD to a 15 year old.  HBP confirmed the patient has no symptoms and no further details to provide.  No other AE and no PQC; This spontaneous report was received from a nurse referred to a 15-year-old patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.   On 28-JUN-2023, the patient was vaccinated with a second dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) administered for prophylaxis (dose, strength, lot #, expiry date, and route of administration were not provided) (Product administered to patient of inappropriate age). The patient has no symptoms and no further details to provide. No other adverse event provided (no adverse event).